Vaneck Vectors Global Health Leaders ETF (ASX: HLTH) Share Price and News

Price

$10.79

Movement

0.16 (+1.51%)

as at 24 Apr - Closed (20 mins delayed)

52 Week Range

$10.36 - $12.50

 
1 Year Return

-0.64%

Vaneck Vectors Global Health Leaders ETF Chart and Price Data

2025
2025
2025
2025
$10
$12
$14
$10
$12
$14
$10
$12
$14
$10
$12
$14

Fundamentals Data provided by Morningstar.

Share Price

$10.79

Day Change

0.16 (+1.51%)

52 Week Range

$10.36 - $12.50

Yesterday's Close

$10.63

Today's Open

$10.79

Days Range

$10.76 - $10.79

Volume

1,482

Avg. Volume (1 month)

7,719

Turnover

$15,988

as at 24 Apr - Closed

  • Vaneck Vectors Global Health Leaders ETF (ASX: HLTH)
    Latest News

    A fit man flexes his muscles, indicating a positive share price movement on the ASX market
    ETFs

    How to invest in US weight loss drug stocks on the ASX

    Want to buy shares in the maker of Ozempic? There's an ASX ETF for that.

    Read more »

    Shot of two young scientists using a laptop in a laboratory.
    Healthcare Shares

    How can ASX investors buy the US stock the WHOLE world is talking about?

    Want to know how to buy the international stock du jour from the comfort of the ASX? Read on!

    Read more »

    medical asx share price represented by doctor giving thumbs up
    ETFs

    'Beyond our expectations': How to invest in obesity drugs like Ozempic with ASX ETFs

    This could be your way to invest in obesity drugs.

    Read more »

    HLTH ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    7th Apr 2025 2025-04-07T10:57:05 Issued Units Outstanding as at 31 March 2025YesNo10:57am4208k
    17th Mar 2025 2025-03-17T17:59:41 Half-Year Financial ReportYesNo5:59pm601M
    7th Mar 2025 2025-03-07T11:51:12 Issued Units Outstanding as at 28 February 2025YesNo11:51am4179k
    17th Feb 2025 2025-02-17T14:04:11 Indicative dividends calendar for 2025YesNo2:04pm3269k
    7th Feb 2025 2025-02-07T12:21:12 Issued Units Outstanding as at 31 January 2025YesNo12:21pm4208k
    8th Jan 2025 2025-01-08T10:19:06 Issued Units Outstanding as at 31 December 2024YesNo10:19am4177k
    6th Dec 2024 2024-12-06T13:23:32 Issued Units Outstanding as at 30 November 2024YesNo1:23pm4168k
    7th Nov 2024 2024-11-07T08:49:37 Issued Units Outstanding as at 31 October 2024YesNo8:49am4199k
    4th Oct 2024 2024-10-04T09:15:30 Issued Units Outstanding as at 30 September 2024YesNo9:15am4198k
    30th Sep 2024 2024-09-30T14:46:45 Annual Report FYE 30 June 2024YesNo2:46pm1411.2M

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael Brown Non-Executive Director
    Mr Brown possesses over 30 years of experience in financial services. Michael is responsible for corporate finance in VanEck's Australian business and for the operations of the Australian funds.
    Mr Bruce Smith Non-Executive Director
    Mr Smith is a Director of various VanEck related entities including Van Eck Associates Corporation, Van Eck Securities Corporation, Van Eck Absolute Return Advisers Corporation and Think ETF Asset Management B.V. He served as Senior Vice President, Chief Financial Officer, Treasurer of Van Eck Associates Corporation, Van Eck Securities Corporation and Van Eck Absolute Return Advisers Corporation until July 2018.
    Mr Jonathan Simon Non-Executive Director
    Mr Simon serves as Senior Vice President, General Counsel, and Secretary for Van Eck Associates Corporation, Van Eck Securities Corporation and Van Eck Absolute Return Advisers Corporation. Prior to joining VanEck, he worked as corporate associate at Sidley Austin LLP, Carter Ledyard & Milburn LLP and Schulte Roth & Zabel LLP. Mr. Simon is a member of the New York State Bar.
    Mr Arian Neiron Non-Executive Director
    Mr Neiron is responsible for the strategy and day-to-day operations of VanEck's Asian Pacific business. Prior to joining VanEck, Arian was a partner at boutique consulting firm Sunstone Partners, specialising in Asset and Wealth Management.
    Mr Jan van Eck Non-Executive Director
    Mr Eck Developed a variety of international, emerging markets, and commodity-related investment strategies in mutual fund, ETF, and alternative investment formats.
    Mr Lee Rappaport Non-Executive Director
    Mr Rappaport serves as Vice President and Chief Financial Officer of Van Eck Associates Corporation and its subsidiaries after previously serving as the Controller. Mr Rappaport also serves as Van Eck Securities Corporation's Financial and Operations Principal. Prior to joining VanEck, Mr Rappaport was a manager at KPMG LLP.
    Mr Timothy Bethe Company SecretaryHead of Operations and Risk
    -
    Timothy Bethe Company SecretaryHead of Operations and Risk
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No top 20 shareholder's information disclosed 0 0.00%

    Profile

    since

    Note